Pharmacology & ToxicologybioRxiv
KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease
M.-H. Nam, J.-H. Park, H. J. Song…·C. J. Lee
This paper tests KDS2010, a reversible MAO-B inhibitor, in PD animal models and finds it effective with low toxicity and superior neuroprotection compared to selegiline.
DOI 10.1007/s13311-021-01097-4